The FDA noted that "CAPA CA 90 was initiated on April 9, 2024, for 731 Series Ventilators with MRI compatibility nonconformances, resulting in a Class I recall that was not initiated until April 30, 2024." The company's complaint analysis system failed to detect the pattern because complaints were coded as "User Errors," "No Fault Found," "No Product Returned," and "User Attempted Repairs." These ventilator failures "caused malfunctions and shutdowns that led to the stoppage of ventilatory support and the need for alternative means of ventilation." Even after closing the CAPA as effective in September 2024, Zoll received 6 complaints relating to the MRI compatibility issues from November 15, 2024, through January 16, 2025, after closure of the CAPA and no additional CAPAs have been initiated
Recently, interest has grown in whether glucagonlike peptide1 receptor agonists (GLP1 RAs)a class of drugs commonly used to manage diabetes and obesitycould help reduce airway inflammation
Human anxiety data exist, mostly from Russian studies, but no trial has tested Selank in fibromyalgia patients
Both physical and mental component scores were improved in the L-carnitine group, but the mental component score was improved in the placebo group as well, resulting in no difference between both groups at 24 weeks
Neither pattern is better or worse
